Veterinary Oncologist, Dr. Kathy Mitchener has been asked to conduct clinical trials for a new treatment that targets Mast Cell Tumors in dogs. Dr. Mitchener, whose AngelCare Cancer Clinic for Animals is located at 6923 Stage Road in Bartlett, TN, is currently seeking pets diagnosed with Grade II Mast Cell Tumors to participate in the trial study.
Nationally renowned for her work in the field of veterinary oncology, as well as that of pain management, Dr. Mitchener is often in the forefront of new developments in veterinary medicine. She was responsible for the release of the first drug developed specifically to treat cancer in dogs, and her tests with other treatments have resulted in bringing benefits to both animal and human cancer sufferers. Dr. Mitchener is hopeful that this latest project will prove similarly successful, bringing relief to dogs suffering with Mast Cell Tumors.
Eligibility for enrollment in the study is limited to dogs that have been diagnosed with a Grade II Mast Cell Tumor, AND have not had previous radiation therapy on the tumor. Additional eligibility guidelines require that, participants have never undergone any previous chemotherapy treatments, and have a life expectancy of greater than two months.
Dog owners interested in finding out if their beloved pet may be eligible to participate in this fully funded study, and receive more information should call (901) 385-9172.
